Core One Labs Inc.: Core One Labs to Rescind Share Exchange with Plant-Based Investment Corp.
Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the
Company or
Core One ) announces that it has reached an agreement with Plant-Based Investment Corp. (formerly, Cannabis Growth Opportunity Corporation) (PBIC) (
PBIC ) to rescind the share exchange transaction previously completed between the parties (the
Share Exchange ).
Effective March 16, 2020, the Company subscribed for and acquired 3,149,606 common shares of PBIC, and in consideration issued 5,333,333 common shares to PBIC (or 2,666,667 common shares after giving effect to the share consolidation completed by the Company on July 8, 2020). The Company and PBIC have agreed to rescind the Share Exchange and return to treasury and cancel all securities of the Company and PBIC issued in connection with the transaction.
Plant-Based Investment Corp.: PBIC To Rescind Share Exchange With Core One Labs
Company ) (
Core One ) to rescind the share exchange transaction previously completed between the parties (the
Share Exchange ).
Effective March 16, 2020, the Company subscribed for and acquired 5,333,333 common shares of Core One (or 2,666,667 common shares of Core One after giving effect to Core One s share consolidation completed on July 8, 2020), and in consideration issued 3,149,606 common shares of PBIC to Core One. The Company and Core One have agreed to rescind the Share Exchange and return to treasury and cancel all securities of the Company and Core One issued in connection with the transaction.
Press release content from Accesswire. The AP news staff was not involved in its creation.
Core One Labs to Rescind Share Exchange with Plant-Based Investment Corp.
April 15, 2021 GMT
VANCOUVER, BC / ACCESSWIRE / April 14, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the Company or Core One ) announces that it has reached an agreement with Plant-Based Investment Corp. (formerly, Cannabis Growth .
VANCOUVER, BC / ACCESSWIRE / April 14, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the Company or Core One ) announces that it has reached an agreement with Plant-Based Investment Corp. (formerly, Cannabis Growth .
Core One Labs to Rescind Share Exchange with Plant-Based Investment Corp digitalfacility.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitalfacility.com Daily Mail and Mail on Sunday newspapers.
The candidates are:
MYCO – 001: a form of pure psilocybin derived from natural fungal sources, targeted to be used at mid-to-late-stage clinical trials.
MYCO – 002: an empathogen with similar effects to MDMA that could have an improved safety profile.
MYCO – 003: a psilocybin-based formula that could diminish the possibility of bad experiences by reducing patient anxiety.
MYCO – 004: a hallucinogen delivered transdermally, offering precision dosing and long-term compound stability.
The claims presented for these compounds need to be proven in clinical trials and via further research.
“By increasing the complexity of these compounds, we are increasing layers of patents applied, which in turn, also adds pharmaceutical value to the drug candidates,” said Joshua Bartch, co-founder and CEO of Mydecine.